Table 14:
Forecasted Uptake Rates of the Prolaris Cell Cycle Progression Test, 2016–2020
Low- or Intermediate-Risk Patients, % | |||
---|---|---|---|
Base Case | Lower Bound | Upper Bound | |
Year 1 | 15 | 5 | 30 |
Year 2 | 25 | 10 | 50 |
Year 3 | 35 | 15 | 70 |
Year 4 | 45 | 20 | 90 |
Year 5 | 55 | 25 | 100 |